BioCryst Pharmaceuticals Inc (BCRX)

BioCryst Pharmaceuticals Inc (BCRX) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2B; returns 1 day -1.7%, 1 week -1.8%, 1 year +6.4%.

BioCryst Pharmaceuticals Inc. (BCRX) is a global biotechnology company primarily focused on discovering, developing, and commercializing oral small-molecule and protein therapeutics for rare and serious diseases, with a particular emphasis on Hereditary Angioedema (HAE) and complement-mediated diseases.

Groups BCRX belongs to

• Biotechnology
• Rare Diseases
• Biopharmaceutical
• Pharmaceuticals
• Commercial Stage
• Commercial Stage Biotech
• Healthcare
• Life Sciences
• Strategic Acquisitions
• Active M&A Strategy

BCRX financial model: income statement, cash flow and balance sheet